OncoDNA's Blood Test to Monitor Tumors

OncoDNA has launched OncoTrace, a non-invasive 28-gene cancer assay. The test uses next generation sequencing technology to analyze circulating tumor DNA and monitor mutations during treatment. Analysis can be done several times and can help inform treatment decisions, the company said.